Last 21.50 INR
Change Today +0.43 / 2.04%
Volume 872.0
As of 6:00 AM 10/1/14 All times are local (Market data is delayed by at least 15 minutes).

resonance specialties ltd (RES) Snapshot

Previous Close
Day High
Day Low
52 Week High
09/12/14 - 27.50
52 Week Low
04/2/14 - 8.85
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

resonance specialties ltd (RES) Related Businessweek News

No Related Businessweek News Found

resonance specialties ltd (RES) Details

Resonance Specialties Limited manufactures and sells pyridines and its derivatives. It offers pyridine, a chemical used in the manufacture of agrochemicals, pharmaceuticals and bulk drugs, dyes, rubber chemicals, etc.; picolines, including alpha picoline used in the vinyl latex rubber, beta picoline used in the manufacture of vitamin B3, and gamma picoline used for the manufacture of anti-tuberculosis drugs; and cyanopyridines. The company also provides drug intermediates and active pharmaceutical ingredients, such as zinc picolinate, chromium picolinate, chromium polynicotinate, niacin, and niacinamide, as well as anti-tuberculosis products, such as isoniazid; and picolinic and dipicolinic acids. In addition, it offers lutidines for use in anti-ulcer drugs, including omeprazol, lansaprazole, and rebaprazole; and collidine that is used in the manufacture of omeprazole and vitamin D3. Resonance Specialties Limited exports its products worldwide through supply agreements with various multinationals, as well as through direct exports. The company, formerly known as Armour Polymers Limited, was incorporated in 1989 and is headquartered in Mumbai, India.

Founded in 1989

resonance specialties ltd (RES) Top Compensated Officers

Managing Director, Executive Director, Member...
Total Annual Compensation: 2.9M
Whole-Time Director
Total Annual Compensation: 893.3K
Compensation as of Fiscal Year 2014.

resonance specialties ltd (RES) Key Developments

Resonance Specialties Limited Reports Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2014

Resonance Specialties Limited reported unaudited standalone earnings results for the first quarter ended June 30, 2014. For the quarter, the company reported net income from operations of INR 819.64 million against INR 104.591 million a year ago. Profit from operations before other income, finance costs & exceptional items was INR 5.112 million against INR 3.836 million a year ago. Profit from ordinary activities before tax was INR 3.796 million against INR 2.175 million a year ago. Net profit from ordinary activities after tax was INR 4.116 million against INR 1.927 million a year ago. Basic and diluted earnings per share were INR 0.36 against INR 0.17 a year ago.

Resonance Specialties Limited, Board Meeting, Aug 14, 2014

Resonance Specialties Limited, Board Meeting, Aug 14, 2014. Agenda: To consider and approve quarterly results.

Resonance Specialties Limited, Annual General Meeting, Aug 14, 2014

Resonance Specialties Limited, Annual General Meeting, Aug 14, 2014., at 11:00 Indian Standard Time. Location: Raheja Classique Club, Infinity Mall.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RES:IN 21.50 INR +0.43

RES Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for RES.
View Industry Companies

Industry Analysis


Industry Average

Valuation RES Industry Range
Price/Earnings 19.0x
Price/Sales 0.5x
Price/Book 1.1x
Price/Cash Flow 10.0x
TEV/Sales 0.4x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RESONANCE SPECIALTIES LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at